Simple strategy could prevent half of deadly tuberculosis infections

Dubbed “Ebola With Wings” for its ability to spread and kill rapidly, XDR TB has been reported in 37 countries and has been identified in all regions of the world, including the United States. The disease has become an epidemic among hospitalized patients in South Africa, according to researchers on the Yale study. Cases of XDR TB have been diagnosed in every province of South Africa, and are particularly concentrated in the area surrounding Tugela Ferry.

To assess the spread of XDR TB, Yale School of Medicine M.D., Ph.D. student Sanjay Basu and the research team developed a computer model of a virtual world that incorporated over two years of data from Tugela Ferry. The model was 95 percent accurate at predicting the trends in XDR and other forms of TB in the region. The Yale study provides the first estimates of the XDR TB burden in South Africa. According to the model over 1,300 cases of XDR TB could arise in the Tugela Ferry region by the end of 2012.

“It is critically important to take steps now to prevent further spread of XDR TB,” said Basu. “If we wait to act, this form of TB will spread further in the community and beyond borders. When a drug resistant strain hit New York in the 1990s, it cost over
$1 billion to bring under control.”

Tuberculosis is caused by bacteria that target the lungs and is spread through the air when an infected person coughs or sneezes. HIV-positive people constitute a vast majority of the XDR TB cases, given their greater risk of infection.

The authors write that the best way to address this type of TB effectively is to change the healthcare environment. Use of masks alone would prevent fewer than 10 percent of cases in the general epidemic, though they would help many healthcare workers, say the researchers. Reducing time spent in the hospital and shifting to outpatient therapy could prevent nearly one-third of cases, they note. About half of XDR TB cases could be prevented by addressing hospital overcrowding, improving ventilation, enhancing access to HIV treatment, and providing faster diagnostic tests, say the study authors.

Basu said that the problem is compounded in South Africa where there are long waiting lists of up to 70 patients hoping to gain admission to hospitals, and crowded wards with as many as 40 people packed into one room. Some of these patients have to sleep on the floor, and many travel for days to reach the hospital.

“We can do a lot to change what is going on,” said senior author Gerald Friedland, M.D., a professor of medicine at Yale. “This is a train crash between the two epidemics of HIV and TB, and we have to address both problems together to fix this situation.”

Source: Yale University

NIAID describes research priorities to fight drug-resistant tuberculosis
Tuberculosis (TB) has long been one of the world’s great killers. Now, forms of drug-resistant TB--multidrug (MDR) and extensively drug-resistant (XDR)--are occurring at an ominous and accelerating rate. To help in the fight against drug-resistant TB, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has formulated an MDR and XDR TB research agenda.
Ending apathy in an age of tuberculosis drug resistance
A primary focus on AIDS and lack of access to cheap life-saving medication has left the world potentially facing an epidemic of virtually untreatable tuberculosis (TB), an ANU academic has warned.
Emerging infectious diseases on the rise: Next target 'hotspot' predicted
It’s not just your imagination. Providing the first-ever definitive proof, a team of scientists has shown that emerging infectious diseases such as HIV, Severe Acute Respiratory Syndrome (SARS), West Nile virus and Ebola are indeed on the rise. The team – including University of Georgia professor John Gittleman and scientists from the Consortium for Conservation Medicine, the Institute of Zoology (London) and Columbia University – recently published their findings in leading scientific journal Nature.
New drug targets may fight tuberculosis and other bacterial infections in novel way
Over the course of the 20th Century, doctors waged war against infectious bacterial illness with the best new weapon they had: antibiotics. But the emergence of dangerous, multi-drug resistant strains of tuberculosis and other killer infections means that in the 21st century antibiotics are losing ground against bacterial disease.
Scientists Decode Genomes of Diverse TB Isolates
An international collaboration led by researchers in the US and South Africa today announced the first genome sequence of an extensively drug resistant (XDR) strain of the bacterium Mycobacterium tuberculosis, one linked to more than 50 deaths in a recent tuberculosis (TB) outbreak in KwaZulu-Natal, South Africa.
Extensively drug-resistant tuberculosis found in California
In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and 77 cases that were one step away from XDR TB. The study appears in the August 15 issue of Clinical Infectious Diseases, now available online.
Comprehensive treatment of extensively drug-resistant TB works, study finds
The death sentence that too often accompanies a diagnosis of extensively drug-resistant tuberculosis (XDR-TB) can be commuted if an individualized outpatient therapy program is followed – even in countries with limited resources and a heavy burden of TB.
Potential treatment for TB solves puzzle
Scientists have uncovered a new target for the potential treatment of TB, finally resolving a long-running debate about how the bacterial cell wall is built. The research, published in the July issue of Microbiology reveals several molecules that could be developed into drugs to treat tuberculosis.

Simple strategy could prevent half of deadly tuberculosis infections

Related stories:

News discussion: